{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:10:37Z","timestamp":1790604637926,"version":"4.1.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioDrugs"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40259-026-00789-7","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:50:06Z","timestamp":1781283006000},"page":"623-640","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Giving Antibiotics a Second Chance: Evolutionary Trade-Offs and Phage-Driven Restoration of Antibiotic Susceptibility"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0573-3337","authenticated-orcid":false,"given":"Micha\u0142","family":"W\u00f3jcicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1352-3778","authenticated-orcid":false,"given":"Martyna","family":"Cie\u015blik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0863-6041","authenticated-orcid":false,"given":"Andrzej","family":"G\u00f3rski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6963-1415","authenticated-orcid":false,"given":"Ewa","family":"Jo\u0144czyk-Matysiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"789_CR1","unstructured":"WHO. Bacteriophages and their use in combating antimicrobial resistance. https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/bacteriophages-and-their-use-in-combating-antimicrobial-resistance. Accessed 8 Dec 2025."},{"key":"789_CR2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-080219-122208","author":"GF Hatfull","year":"2022","unstructured":"Hatfull GF, Dedrick RM, Schooley RT. Phage therapy for antibiotic-resistant bacterial infections. Annu Rev Med. 2022. https:\/\/doi.org\/10.1146\/annurev-med-080219-122208.","journal-title":"Annu Rev Med"},{"key":"789_CR3","doi-asserted-by":"publisher","DOI":"10.1101\/2023.01.23.22283996","author":"BK Chan","year":"2023","unstructured":"Chan BK, Stanley GL, Kortright KE, Modak M, Ott IM, Sun Y, et al. Personalized inhaled bacteriophage therapy decreases multidrug-resistant Pseudomonas aeruginosa. medRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.01.23.22283996.","journal-title":"medRxiv"},{"key":"789_CR4","doi-asserted-by":"publisher","DOI":"10.47772\/IJRISS.2025.903SEDU0395","author":"JAV Espinal","year":"2025","unstructured":"Espinal JAV, Garc\u00eda JA, Espinal JEV, Echenoa KA, Gonzalez DAM, Chimal GA, et al. Revolutionizing infection control: the role of bacteriophage therapy in combating antimicrobial resistance. Int J Res Innov Soc Sci. 2025. https:\/\/doi.org\/10.47772\/IJRISS.2025.903SEDU0395.","journal-title":"Int J Res Innov Soc Sci"},{"key":"789_CR5","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S428837","author":"H Endale","year":"2023","unstructured":"Endale H, Mathewos M, Abdeta D. Potential causes of spread of antimicrobial resistance and preventive measures in one health perspective\u2014a review. Infect Drug Resist. 2023. https:\/\/doi.org\/10.2147\/IDR.S428837.","journal-title":"Infect Drug Resist."},{"key":"789_CR6","doi-asserted-by":"publisher","DOI":"10.14202\/vetworld.2022.662-671","author":"MMJ Ars\u00e8ne","year":"2022","unstructured":"Ars\u00e8ne MMJ, Davares AKL, Viktorovna PI, Andreevna SL, Sarra S, Khelifi I, et al. The public health issue of antibiotic residues in food and feed: Causes, consequences, and potential solutions. Vet World. 2022. https:\/\/doi.org\/10.14202\/vetworld.2022.662-671.","journal-title":"Vet World."},{"key":"789_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab450","author":"G Liu","year":"2022","unstructured":"Liu G, Thomsen LE, Olsen JE. Antimicrobial-induced horizontal transfer of antimicrobial resistance genes in bacteria: a mini-review. J Antimicrob Chemother. 2022. https:\/\/doi.org\/10.1093\/jac\/dkab450.","journal-title":"J Antimicrob Chemother"},{"key":"789_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cofs.2022.100882","author":"PG Vinayamohan","year":"2022","unstructured":"Vinayamohan PG, Pellissery AJ, Venkitanarayanan K. Role of horizontal gene transfer in the dissemination of antimicrobial resistance in food animal production. Curr Opin Food Sci. 2022. https:\/\/doi.org\/10.1016\/j.cofs.2022.100882.","journal-title":"Curr Opin Food Sci"},{"key":"789_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14030296","author":"NS Olsen","year":"2025","unstructured":"Olsen NS, Riber L. Metagenomics as a transformative tool for antibiotic resistance surveillance: highlighting the impact of mobile genetic elements with a focus on the complex role of phages. Antibiotics. 2025. https:\/\/doi.org\/10.3390\/antibiotics14030296.","journal-title":"Antibiotics"},{"key":"789_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fsysb.2025.1557413","author":"R Kumavath","year":"2025","unstructured":"Kumavath R, Gupta P, Tatta ER, Mohan MS, Salim SA, Busi S. Unraveling the role of mobile genetic elements in antibiotic resistance transmission and defense strategies in bacteria. Front Syst Biol. 2025. https:\/\/doi.org\/10.3389\/fsysb.2025.1557413.","journal-title":"Front Syst Biol."},{"key":"789_CR11","doi-asserted-by":"publisher","DOI":"10.46784\/e-avm.v17i1.361","author":"S Qasim","year":"2024","unstructured":"Qasim S, Khan AU, Raza A. Zoonotic diseases and antimicrobial resistance: a dual threat at the human-animal interface. Arch Vet Med. 2024. https:\/\/doi.org\/10.46784\/e-avm.v17i1.361.","journal-title":"Arch Vet Med"},{"key":"789_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14060543","author":"Z Ye","year":"2025","unstructured":"Ye Z, Li M, Jing Y, Liu K, Wu Y, Peng Z. What are the drivers triggering antimicrobial resistance emergence and spread? Outlook from a One Health perspective. Antibiotics. 2025. https:\/\/doi.org\/10.3390\/antibiotics14060543.","journal-title":"Antibiotics"},{"key":"789_CR13","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.3c00625","author":"S Singh","year":"2024","unstructured":"Singh S, Sharma P, Pal N, Sarma DK, Tiwari R, Kumar M. Holistic one health surveillance framework: synergizing environmental, animal, and human determinants for enhanced infectious disease management. ACS Infect Dis. 2024. https:\/\/doi.org\/10.1021\/acsinfecdis.3c00625.","journal-title":"ACS Infect Dis."},{"key":"789_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12091920","author":"M Oliveira","year":"2024","unstructured":"Oliveira M, Antunes W, Mota S, Madureira-Carvalho \u00c1, Dinis-Oliveira RJ, Dias da Silva D. An overview of the recent advances in antimicrobial resistance. Microorganisms. 2024. https:\/\/doi.org\/10.3390\/microorganisms12091920.","journal-title":"Microorganisms"},{"key":"789_CR15","doi-asserted-by":"publisher","DOI":"10.4236\/pp.2023.148020","author":"S Mudenda","year":"2023","unstructured":"Mudenda S, Chabalenge B, Daka V, Mfune RL, Salachi KI, Mohamed S, et al. Global strategies to combat antimicrobial resistance: a one health perspective. Pharmacol Pharm. 2023. https:\/\/doi.org\/10.4236\/pp.2023.148020.","journal-title":"Pharmacol Pharm"},{"key":"789_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14010038","author":"O Horvat","year":"2025","unstructured":"Horvat O, Kova\u010devi\u0107 Z. Human and veterinary medicine collaboration: synergistic approach to address antimicrobial resistance through the lens of planetary health. Antibiotics. 2025. https:\/\/doi.org\/10.3390\/antibiotics14010038.","journal-title":"Antibiotics"},{"key":"789_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14101040","author":"S Zhang","year":"2025","unstructured":"Zhang S, Ahn J. Phage therapy as a novel alternative to antibiotics through adaptive evolution and fitness trade-offs. Antibiotics. 2025. https:\/\/doi.org\/10.3390\/antibiotics14101040.","journal-title":"Antibiotics"},{"key":"789_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2026.1778984","author":"JAG Fortaleza","year":"2026","unstructured":"Fortaleza JAG, Cabuhat KSP, Kim S, Mortel FA, Bacalzo GD, Nuevo JJM. Bacteriophages targeting Acinetobacter baumannii in the era of antibiotic failure: a review. Front Microbiol. 2026. https:\/\/doi.org\/10.3389\/fmicb.2026.1778984.","journal-title":"Front Microbiol"},{"key":"789_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biom15081182","author":"CT Ekwueme","year":"2025","unstructured":"Ekwueme CT, Anyiam IV, Ekwueme DC, Anumudu CK, Onyeaka H. Reconstructing the antibiotic pipeline: natural alternatives to antibacterial agents. Biomolecules. 2025. https:\/\/doi.org\/10.3390\/biom15081182.","journal-title":"Biomolecules"},{"key":"789_CR20","doi-asserted-by":"publisher","DOI":"10.3126\/jmcjms.v12i02.69144","author":"RR Kasarla","year":"2024","unstructured":"Kasarla RR, Kasarla RR, Thummala SR, Pathak L. Bacteriophage therapy: an alternative to antibiotics in the age of multi-drug resistance. Janaki Med Coll J Med Sci. 2024. https:\/\/doi.org\/10.3126\/jmcjms.v12i02.69144.","journal-title":"Janaki Med Coll J Med Sci."},{"key":"789_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/foods13162519","author":"D Shymialevich","year":"2024","unstructured":"Shymialevich D, W\u00f3jcicki M, Soko\u0142owska B. The novel concept of synergically combining: high hydrostatic pressure and lytic bacteriophages to eliminate vegetative and spore-forming bacteria in food products. 2024. Foods. https:\/\/doi.org\/10.3390\/foods13162519."},{"key":"789_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ph16121638","author":"B Zalewska-Pi\u0105tek","year":"2023","unstructured":"Zalewska-Pi\u0105tek B. Phage therapy\u2014challenges, opportunities and future prospects. Pharmaceuticals. 2023. https:\/\/doi.org\/10.3390\/ph16121638.","journal-title":"Pharmaceuticals"},{"key":"789_CR23","doi-asserted-by":"publisher","DOI":"10.17306\/J.AFS.2019.0695","author":"M W\u00f3jcicki","year":"2019","unstructured":"W\u00f3jcicki M, B\u0142a\u017cejak S, Gientka I, Brzezicka K. The concept of using bacteriophages to improve the microbiological quality of minimally processed foods. Acta Sci Pol Technol Aliment. 2019. https:\/\/doi.org\/10.17306\/J.AFS.2019.0695.","journal-title":"Acta Sci Pol Technol Aliment"},{"issue":"1","key":"789_CR24","first-page":"36","volume":"1","author":"H Purane","year":"2023","unstructured":"Purane H, Andhale S, Kshirsagar M, Rasve V, Garje S, Lad SD. Antibiotics resistance and bacteriophage therapy. Int J Res Pharm Allied Sci. 2023;1(1):36\u201347.","journal-title":"Int J Res Pharm Allied Sci."},{"key":"789_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/26416549251366991","author":"A Hanafiah","year":"2025","unstructured":"Hanafiah A, Sukri A, Asmawi MA, Yusoff H, Mohd Puzi S, Neoh HM, et al. Recent advancements in development and characterization of phages targeting Helicobacter pylori. PHAGE. 2025. https:\/\/doi.org\/10.1177\/26416549251366991.","journal-title":"PHAGE"},{"key":"789_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00062-22","author":"L Marongiu","year":"2022","unstructured":"Marongiu L, Burkard M, Lauer UM, Hoelzle LE, Venturelli S. Reassessment of historical clinical trials supports the effectiveness of phage therapy. Clin Microbiol Rev. 2022. https:\/\/doi.org\/10.1128\/cmr.00062-22.","journal-title":"Clin Microbiol Rev"},{"key":"789_CR27","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297920090096","author":"AV Letarov","year":"2020","unstructured":"Letarov AV. History of early bacteriophage research and emergence of key concepts in virology. Biochemistry. 2020. https:\/\/doi.org\/10.1134\/S0006297920090096.","journal-title":"Biochemistry"},{"key":"789_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s12223-016-0471-x","author":"S Sharma","year":"2017","unstructured":"Sharma S, Chatterjee S, Datta S, Prasad R, Dubey D, Prasad RK, et al. Bacteriophages and its applications: an overview. Folia Microbiol. 2017. https:\/\/doi.org\/10.1007\/s12223-016-0471-x.","journal-title":"Folia Microbiol"},{"key":"789_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2022.2013809","author":"L Bottalico","year":"2022","unstructured":"Bottalico L, Charitos IA, Potenza MA, Montagnani M, Santacroce L. The war against bacteria, from the past to present and beyond. Expert Rev Anti-infect Ther. 2022. https:\/\/doi.org\/10.1080\/14787210.2022.2013809.","journal-title":"Expert Rev Anti-infect Ther."},{"key":"789_CR30","doi-asserted-by":"publisher","DOI":"10.7324\/JAPS.2022.120502","author":"I Durbas","year":"2022","unstructured":"Durbas I, Machnik G. Phage therapy: an old concept with new perspectives. J Appl Pharm Sci. 2022. https:\/\/doi.org\/10.7324\/JAPS.2022.120502.","journal-title":"J Appl Pharm Sci."},{"issue":"1","key":"789_CR31","first-page":"135","volume":"90","author":"M Lobanovska","year":"2017","unstructured":"Lobanovska M, Pilla G. Penicillin\u2019s discovery and antibiotic resistance: lessons for the future? Yale J Biol Med. 2017;90(1):135\u201345.","journal-title":"Yale J Biol Med"},{"key":"789_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10050578","author":"CX Low","year":"2021","unstructured":"Low CX, Tan LT-H, Ab Mutalib N-S, Pusparajah P, Goh B-H, Chan K-G, et al. Unveiling the impact of antibiotics and alternative methods for animal husbandry: a review. Antibiotics. 2021. https:\/\/doi.org\/10.3390\/antibiotics10050578.","journal-title":"Antibiotics"},{"key":"789_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8030085","author":"H Sakkas","year":"2019","unstructured":"Sakkas H, Bozidis P, Ilia A, Mpekoulis G, Papadopoulou C. Antimicrobial resistance in bacterial pathogens and detection of carbapenemases in Klebsiella pneumoniae isolates from hospital wastewater. Antibiotics. 2019. https:\/\/doi.org\/10.3390\/antibiotics8030085.","journal-title":"Antibiotics"},{"key":"789_CR34","first-page":"90","volume":"4","author":"E Etebu","year":"2016","unstructured":"Etebu E, Arikekpar I. Antibiotics: classification and mechanisms of action with emphasis on molecular perspectives. Int J Appl Microbiol Biotechnol Res. 2016;4:90\u2013101.","journal-title":"Int J Appl Microbiol Biotechnol Res."},{"key":"789_CR35","doi-asserted-by":"publisher","DOI":"10.30574\/gscbps.2021.14.2.0037","author":"S Begum","year":"2021","unstructured":"Begum S, Begum T, Rahman N, Khan RA. A review on antibiotic resistance and way of combating antimicrobial resistance. GSC Biol Pharm Sci. 2021. https:\/\/doi.org\/10.30574\/gscbps.2021.14.2.0037.","journal-title":"GSC Biol Pharm Sci."},{"key":"789_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.elecom.2020.106863","author":"Z Bitew","year":"2020","unstructured":"Bitew Z, Amare M. Recent reports on electrochemical determination of selected antibiotics in pharmaceutical formulations: a mini review. Electrochem Commun. 2020. https:\/\/doi.org\/10.1016\/j.elecom.2020.106863.","journal-title":"Electrochem Commun"},{"key":"789_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10080995","author":"D Carcione","year":"2021","unstructured":"Carcione D, Siracusa C, Sulejmani A, Leoni V, Intra J. Old and new beta-lactamase inhibitors: molecular structure, mechanism of action, and clinical use. Antibiotics. 2021. https:\/\/doi.org\/10.3390\/antibiotics10080995.","journal-title":"Antibiotics"},{"key":"789_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2023.215326","author":"M Zabiszak","year":"2023","unstructured":"Zabiszak M, Frymark J, Ogawa K, Skroba\u0144ska M, Nowak M, Jastrzab R, et al. Complexes of \u03b2-lactam antibiotics and their Schiff-base derivatives as a weapon in the fight against bacterial resistance. Coord Chem Rev. 2023. https:\/\/doi.org\/10.1016\/j.ccr.2023.215326.","journal-title":"Coord Chem Rev"},{"key":"789_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.111901","author":"H Fatima","year":"2021","unstructured":"Fatima H, Goel N, Sinha R, Khare SK. Recent strategies for inhibiting multidrug-resistant and \u03b2-lactamase producing bacteria: a review. Colloids Surf B Biointerfaces. 2021. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111901.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"789_CR40","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01202-19","author":"CA Smith","year":"2019","unstructured":"Smith CA, Stewart NK, Toth M, Vakulenko SB. Structural insights into the mechanism of carbapenemase activity of the OXA-48 \u03b2-lactamase. Antimicrob Agents Chemother. 2019. https:\/\/doi.org\/10.1128\/aac.01202-19.","journal-title":"Antimicrob Agents Chemother"},{"key":"789_CR41","first-page":"273","volume-title":"Macromolecular protein complexes II: structure and function","author":"MM Miyachiro","year":"2020","unstructured":"Miyachiro MM, Contreras-Martel C, Dessen A. Penicillin-binding proteins (PBPs) and bacterial cell wall elongation complexes. In: Harris J, Marles-Wright J, editors. Macromolecular protein complexes II: structure and function. Cham: Springer; 2020. p. 273\u201389."},{"key":"789_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/molecules171112478","author":"A Zervosen","year":"2012","unstructured":"Zervosen A, Sauvage E, Fr\u00e8re J-M, Charlier P, Luxen A. Development of new drugs for an old target\u2014the penicillin binding proteins. Molecules. 2012. https:\/\/doi.org\/10.3390\/molecules171112478.","journal-title":"Molecules"},{"key":"789_CR43","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.1c00367","author":"Y Acharya","year":"2021","unstructured":"Acharya Y, Bhattacharyya S, Dhanda G, Haldar J. Emerging roles of glycopeptide antibiotics: moving beyond gram-positive bacteria. ACS Infect Dis. 2021. https:\/\/doi.org\/10.1021\/acsinfecdis.1c00367.","journal-title":"ACS Infect Dis"},{"key":"789_CR44","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S199119","author":"SMR Hashemian","year":"2019","unstructured":"Hashemian SMR, Farhadi Z, Farhadi T. Fosfomycin: the characteristics, activity, and use in critical care. Ther Clin Risk Manag. 2019. https:\/\/doi.org\/10.2147\/TCRM.S199119.","journal-title":"Ther Clin Risk Manag"},{"issue":"10","key":"789_CR45","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025288","volume":"6","author":"MJ Trimble","year":"2016","unstructured":"Trimble MJ, Mlyn\u00e1r\u010dik P, Kol\u00e1\u0159 M, Hancock REW. Polymyxin: alternative mechanisms of action and resistance. Cold Spring Harb Perspect Med. 2016;6(10):a025288.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"789_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9010017","author":"DA Gray","year":"2020","unstructured":"Gray DA, Wenzel M. More than a pore: a current perspective on the in vivo mode of action of the lipopeptide antibiotic daptomycin. Antibiotics (Basel). 2020. https:\/\/doi.org\/10.3390\/antibiotics9010017.","journal-title":"Antibiotics (Basel)"},{"key":"789_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13050347","author":"KD Lenz","year":"2021","unstructured":"Lenz KD, Klosterman KE, Mukundan H, Kubicek-Sutherland JZ. Macrolides: from toxins to therapeutics. Toxins (Basel). 2021. https:\/\/doi.org\/10.3390\/toxins13050347.","journal-title":"Toxins (Basel)"},{"key":"789_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2016.12.001","author":"J Sp\u00ed\u017eek","year":"2017","unstructured":"Sp\u00ed\u017eek J, \u0158ezanka T. Lincosamides: chemical structure, biosynthesis, mechanism of action, resistance, and applications. Biochem Pharmacol. 2017. https:\/\/doi.org\/10.1016\/j.bcp.2016.12.001.","journal-title":"Biochem Pharmacol"},{"key":"789_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(03)00662-4","author":"T Tenson","year":"2003","unstructured":"Tenson T, Lovmar M, Ehrenberg M. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J Mol Biol. 2003. https:\/\/doi.org\/10.1016\/S0022-2836(03)00662-4.","journal-title":"J Mol Biol"},{"issue":"14","key":"789_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26144280","volume":"26","author":"C Foti","year":"2021","unstructured":"Foti C, Piperno A, Scala A, Giuffr\u00e8 O. Oxazolidinone antibiotics: chemical, biological and analytical aspects. Molecules. 2021;26(14):4280. https:\/\/doi.org\/10.3390\/molecules26144280.","journal-title":"Molecules"},{"issue":"1","key":"789_CR51","first-page":"48","volume":"10","author":"MS Jain","year":"2020","unstructured":"Jain MS, Barhate SD. Tigecycline is the first clinically-available drug in a new class of antibiotics called the glycylcyclines: a review. Asian J Pharm Technol. 2020;10(1):48.","journal-title":"Asian J Pharm Technol"},{"key":"789_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/der2.49","author":"EM Graber","year":"2021","unstructured":"Graber EM. Treating acne with the tetracycline class of antibiotics: a review. Dermatol Rev. 2021. https:\/\/doi.org\/10.1002\/der2.49.","journal-title":"Dermatol Rev"},{"issue":"23","key":"789_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25235662","volume":"25","author":"NG Bush","year":"2020","unstructured":"Bush NG, Diez-Santos I, Abbott LR, Maxwell A. Quinolones: mechanism, lethality and their contributions to antibiotic resistance. Molecules. 2020;25(23):5662. https:\/\/doi.org\/10.3390\/molecules25235662.","journal-title":"Molecules"},{"issue":"5","key":"789_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/biology10050388","volume":"10","author":"C Thomas","year":"2021","unstructured":"Thomas C, Gwenin CD. The role of nitroreductases in resistance to nitroimidazoles. Biology (Basel). 2021;10(5):388. https:\/\/doi.org\/10.3390\/biology10050388.","journal-title":"Biology (Basel)"},{"key":"789_CR55","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00143","author":"CW Ang","year":"2017","unstructured":"Ang CW, Jarrad AM, Cooper MA, Blaskovich MAT. Nitroimidazoles: molecular fireworks that combat a broad spectrum of infectious diseases. J Med Chem. 2017. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00143.","journal-title":"J Med Chem"},{"key":"789_CR56","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01066-13","author":"MP Draper","year":"2014","unstructured":"Draper MP, Weir S, Macone A, Donatelli J, Trieber CA, Tanaka SK, et al. Mechanism of action of the novel aminomethylcycline antibiotic omadacycline. Antimicrob Agents Chemother. 2014. https:\/\/doi.org\/10.1128\/aac.01066-13.","journal-title":"Antimicrob Agents Chemother"},{"key":"789_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-020-10982-5","author":"OC Nunes","year":"2020","unstructured":"Nunes OC, Manaia CM, Kolvenbach BA, Corvini PF-X. Living with sulfonamides: a diverse range of mechanisms observed in bacteria. Appl Microbiol Biotechnol. 2020. https:\/\/doi.org\/10.1007\/s00253-020-10982-5.","journal-title":"Appl Microbiol Biotechnol"},{"key":"789_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2021.10.020","author":"TM Uddin","year":"2021","unstructured":"Uddin TM, Chakraborty AJ, Khusro A, Zidan BMRM, Mitra S, Emran TB, et al. Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects. J Infect Public Health. 2021. https:\/\/doi.org\/10.1016\/j.jiph.2021.10.020.","journal-title":"J Infect Public Health"},{"key":"789_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25010116","author":"A Wr\u00f3bel","year":"2020","unstructured":"Wr\u00f3bel A, Maliszewski D, Baradyn M, Drozdowska D. Trimethoprim: an old antibacterial drug as a template to search for new targets. Synthesis, biological activity and molecular modeling study of novel trimethoprim analogs. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25010116.","journal-title":"Molecules"},{"key":"789_CR60","doi-asserted-by":"publisher","DOI":"10.47750\/jptcp.2023.30.05.047","author":"HM Al-Hasani","year":"2023","unstructured":"Al-Hasani HM, Al-Rubaye DS, Abdelhameed A. The emergence of multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) in Iraqi clinical isolates of Escherichia coli. J Popul Ther Clin Pharmacol. 2023. https:\/\/doi.org\/10.47750\/jptcp.2023.30.05.047.","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"789_CR61","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1945922","author":"PI Rafailidis","year":"2022","unstructured":"Rafailidis PI, Kofteridis D. Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria. Expert Rev Anti Infect Ther. 2022. https:\/\/doi.org\/10.1080\/14787210.2021.1945922.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"789_CR62","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S283488","author":"H Alkofide","year":"2020","unstructured":"Alkofide H, Alhammad AM, Alruwaili A, Aldemerdash A, Almangour TA, Alsuwayegh A, et al. Multidrug-resistant and extensively drug-resistant Enterobacteriaceae: prevalence, treatments, and outcomes\u2014a retrospective cohort study. Infect Drug Resist. 2020. https:\/\/doi.org\/10.2147\/IDR.S283488.","journal-title":"Infect Drug Resist."},{"issue":"6","key":"789_CR63","first-page":"817","volume":"11","author":"TH Hasan","year":"2020","unstructured":"Hasan TH, Al-Harmoosh RA. Mechanisms of antibiotics resistance in bacteria. Syst Rev Pharm. 2020;11(6):817\u201323.","journal-title":"Syst Rev Pharm."},{"key":"789_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10040415","author":"L Kakoullis","year":"2021","unstructured":"Kakoullis L, Papachristodoulou E, Chra P, Panos G. Mechanisms of antibiotic resistance in important Gram-positive and Gram-negative pathogens and novel antibiotic solutions. Antibiotics. 2021. https:\/\/doi.org\/10.3390\/antibiotics10040415.","journal-title":"Antibiotics"},{"key":"789_CR65","unstructured":"World Health Organization. WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240093461. Accessed 20 Dec 2025."},{"key":"789_CR66","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1928633","author":"P Chandra","year":"2021","unstructured":"Chandra P, Unnikrishnan MK, Vandana KE, Mukhopadhyay C, Dinesh Acharya U, Surulivel Rajan M, et al. Antimicrobial resistance and the post antibiotic era: better late than never effort. Expert Opin Drug Saf. 2021. https:\/\/doi.org\/10.1080\/14740338.2021.1928633.","journal-title":"Expert Opin Drug Saf"},{"key":"789_CR67","doi-asserted-by":"publisher","DOI":"10.5530\/jyp.2019.11.69","author":"RP Priyadharsini","year":"2019","unstructured":"Priyadharsini RP. Antibiotic resistance: What is there in past, present and future? J Young Pharm. 2019. https:\/\/doi.org\/10.5530\/jyp.2019.11.69.","journal-title":"J Young Pharm"},{"key":"789_CR68","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S317665","author":"A Kose","year":"2021","unstructured":"Kose A, Colak C. Knowledge and awareness of physicians about rational antibiotic use and antimicrobial resistance before and after graduation: a cross\u2013sectional study conducted in Malatya Province in Turkey. Infect Drug Resist. 2021. https:\/\/doi.org\/10.2147\/IDR.S317665.","journal-title":"Infect Drug Resist."},{"key":"789_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2018.11.040","author":"Y Ben","year":"2019","unstructured":"Ben Y, Fu C, Hu M, Liu L, Wong MH, Zheng C. Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: a review. Environ Res. 2019. https:\/\/doi.org\/10.1016\/j.envres.2018.11.040.","journal-title":"Environ Res"},{"key":"789_CR70","doi-asserted-by":"publisher","DOI":"10.1021\/acs.est.7b03623","author":"PJ Vikesland","year":"2017","unstructured":"Vikesland PJ, Pruden A, Alvarez PJJ, Aga D, B\u00fcrgmann H, Li XD, et al. Toward a comprehensive strategy to mitigate dissemination of environmental sources of antibiotic resistance. Environ Sci Technol. 2017. https:\/\/doi.org\/10.1021\/acs.est.7b03623.","journal-title":"Environ Sci Technol"},{"key":"789_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/499398a","author":"B Mole","year":"2013","unstructured":"Mole B. MRSA: farming up trouble. Nature. 2013. https:\/\/doi.org\/10.1038\/499398a.","journal-title":"Nature"},{"key":"789_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112626","author":"N Wang","year":"2014","unstructured":"Wang N, Yang X, Jiao S, Zhang J, Ye B, Gao S. Sulfonamide\u2013resistant bacteria and their resistance genes in soils fertilized with manures from Jiangsu Province. Southeastern China PLoS One. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0112626.","journal-title":"Southeastern China. PLoS One."},{"key":"789_CR73","doi-asserted-by":"publisher","DOI":"10.1177\/2042098614554919","author":"C Llor","year":"2014","unstructured":"Llor C, Bjerrum L. Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014. https:\/\/doi.org\/10.1177\/2042098614554919.","journal-title":"Ther Adv Drug Saf."},{"key":"789_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.07.031","author":"TTH Van","year":"2020","unstructured":"Van TTH, Yidana Z, Smooker PM, Coloe PJ. Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses. J Glob Antimicrob Resist. 2020. https:\/\/doi.org\/10.1016\/j.jgar.2019.07.031.","journal-title":"J Glob Antimicrob Resist"},{"key":"789_CR75","first-page":"34","volume":"2","author":"R Bisht","year":"2009","unstructured":"Bisht R, Katiyar A, Singh R, Mittal P. Antibiotic resistance\u2014a global issue of concern. Asian J Pharm Clin Res. 2009;2:34\u20139.","journal-title":"Asian J Pharm Clin Res"},{"key":"789_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bsheal.2020.09.004","author":"F Ma","year":"2021","unstructured":"Ma F, Xu S, Tang Z, Li Z, Zhang L. Use of antimicrobials in food animals and impact of transmission of antimicrobial resistance on humans. Biosaf Health. 2021. https:\/\/doi.org\/10.1016\/j.bsheal.2020.09.004.","journal-title":"Biosaf Health."},{"key":"789_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2016.06.004","author":"AS Chaudhary","year":"2016","unstructured":"Chaudhary AS. A review of global initiatives to fight antibiotic resistance and recent antibiotics\u05f3 discovery. Acta Pharm Sin B. 2016. https:\/\/doi.org\/10.1016\/j.apsb.2016.06.004.","journal-title":"Acta Pharm Sin B."},{"key":"789_CR78","doi-asserted-by":"publisher","DOI":"10.60787\/wapcp-33-2-258","author":"IA Suleiman","year":"2022","unstructured":"Suleiman IA, Aremu TO, Aremu OK. Epidemiology of antimicrobial resistance and its clinical, economic and humanistic outcomes in developing countries. West Afr J Pharm. 2022. https:\/\/doi.org\/10.60787\/wapcp-33-2-258.","journal-title":"West Afr J Pharm."},{"key":"789_CR79","doi-asserted-by":"publisher","DOI":"10.4137\/PMC.S14459","author":"RJ Fair","year":"2014","unstructured":"Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Med Chem. 2014. https:\/\/doi.org\/10.4137\/PMC.S14459.","journal-title":"Perspect Med Chem"},{"key":"789_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12982-025-00859-1","author":"J Esther","year":"2025","unstructured":"Esther J, Onyebuchi OB, Eugenia OE, Ann OC, Adamma NM, Chiaka IG, et al. Antimicrobial resistance in Nigeria\u2019s healthcare system: a comprehensive narrative review and policy implications. Discov Public Health. 2025. https:\/\/doi.org\/10.1186\/s12982-025-00859-1.","journal-title":"Discov Public Health."},{"key":"789_CR81","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.778827","author":"YH Chen","year":"2013","unstructured":"Chen YH, Ko WC, Hsueh PR. Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections. Expert Opin Pharmacother. 2013. https:\/\/doi.org\/10.1517\/14656566.2013.778827.","journal-title":"Expert Opin Pharmacother"},{"key":"789_CR82","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00047-19","author":"K Bush","year":"2020","unstructured":"Bush K, Bradford PA. Epidemiology of \u03b2-lactamase-producing pathogens. Clin Microbiol Rev. 2020. https:\/\/doi.org\/10.1128\/cmr.00047-19.","journal-title":"Clin Microbiol Rev"},{"key":"789_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14121254","author":"F Khalid","year":"2025","unstructured":"Khalid F, Aljohani WJ, Akram A, Bukhari A, Khojah OT. Epidemiology and antimicrobial resistance of uropathogens in a Tertiary Care Center in Riyadh, Saudi Arabia: a one-year retrospective analysis. Pathogens. 2025. https:\/\/doi.org\/10.3390\/pathogens14121254.","journal-title":"Pathogens"},{"key":"789_CR84","first-page":"5","volume":"4","author":"RA Oluwafemi","year":"2020","unstructured":"Oluwafemi RA, Olawale I, Alagbe JO. Recent trends in the utilization of medicinal plants as growth promoters in poultry nutrition\u2014a review. Res Agric Vet Sci. 2020;4:5\u201311.","journal-title":"Res Agric Vet Sci."},{"key":"789_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250082","author":"NV Cuong","year":"2021","unstructured":"Cuong NV, Kiet BT, Hien VB, Truong BD, Phu DH, Thwaites G, et al. Antimicrobial use through consumption of medicated feeds in chicken flocks in the Mekong Delta of Vietnam: a three\u2013year study before a ban on antimicrobial growth promoters. PLoS ONE. 2021. https:\/\/doi.org\/10.1371\/journal.pone.0250082.","journal-title":"PLoS ONE"},{"key":"789_CR86","unstructured":"Council of the European Union. Programme of Community action in the field of public health (2003 to 2008). https:\/\/eur-lex.europa.eu\/legal-content\/EN\/ALL\/?uri=LEGISSUM:c11503b Accessed 20 Dec 2025."},{"key":"789_CR87","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S251171","author":"M Taati Moghadam","year":"2020","unstructured":"Taati Moghadam M, Khoshbayan A, Chegini Z, Farahani I, Shariati A. Bacteriophages, a new therapeutic solution for inhibiting multidrug\u2013resistant bacteria causing wound infection: lesson from animal models and clinical trials. Drug Des Devel Ther. 2020. https:\/\/doi.org\/10.2147\/DDDT.S251171.","journal-title":"Drug Des Devel Ther"},{"key":"789_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10060672","author":"A Broncano-Lavado","year":"2021","unstructured":"Broncano-Lavado A, Santamar\u00eda-Corral G, Esteban J, Garc\u00eda-Quintanilla M. Advances in bacteriophage therapy against relevant multidrug\u2013resistant pathogens. Antibiotics (Basel). 2021. https:\/\/doi.org\/10.3390\/antibiotics10060672.","journal-title":"Antibiotics (Basel)"},{"key":"789_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9030135","author":"MP Nikolich","year":"2020","unstructured":"Nikolich MP, Filippov AA. Bacteriophage therapy: developments and directions. Antibiotics (Basel). 2020. https:\/\/doi.org\/10.3390\/antibiotics9030135.","journal-title":"Antibiotics (Basel)"},{"key":"789_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107886","author":"S Zhang","year":"2025","unstructured":"Zhang S, Ahn J. Adaptive trade-offs between bacteriophage and antibiotic resistance in Salmonella Typhimurium. Microb Pathog. 2025. https:\/\/doi.org\/10.1016\/j.micpath.2025.107886.","journal-title":"Microb Pathog"},{"key":"789_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00806-1","author":"M \u0141usiak-Szelachowska","year":"2022","unstructured":"\u0141usiak-Szelachowska M, Mi\u0119dzybrodzki R, Drulis-Kawa Z, Cater K, Kne\u017eevi\u0107 P, Winogradow C, et al. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far. J Biomed Sci. 2022. https:\/\/doi.org\/10.1186\/s12929-022-00806-1.","journal-title":"J Biomed Sci"},{"key":"789_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/v10070351","author":"F Oechslin","year":"2018","unstructured":"Oechslin F. Resistance development to bacteriophages occurring during bacteriophage therapy. Viruses. 2018. https:\/\/doi.org\/10.3390\/v10070351.","journal-title":"Viruses"},{"key":"789_CR93","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-012423-110530","author":"A Orom\u00ed-Bosch","year":"2023","unstructured":"Orom\u00ed-Bosch A, Antani JD, Turner PE. Developing phage therapy that overcomes the evolution of bacterial resistance. Annu Rev Virol. 2023. https:\/\/doi.org\/10.1146\/annurev-virology-012423-110530.","journal-title":"Annu Rev Virol"},{"key":"789_CR94","doi-asserted-by":"publisher","DOI":"10.1086\/717897","author":"JT Garland Jr","year":"2022","unstructured":"Garland JT Jr, Downs CJ, Ives AR. Trade-offs (and constraints) in organismal biology. Physiol Biochem Zool. 2022. https:\/\/doi.org\/10.1086\/717897.","journal-title":"Physiol Biochem Zool"},{"key":"789_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11070915","author":"M Hasan","year":"2022","unstructured":"Hasan M, Ahn J. Evolutionary dynamics between phages and bacteria as a possible approach for designing effective phage therapies against antibiotic-resistant bacteria. Antibiotics (Basel). 2022. https:\/\/doi.org\/10.3390\/antibiotics11070915.","journal-title":"Antibiotics (Basel)"},{"key":"789_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e40076","author":"AS Mary","year":"2024","unstructured":"Mary AS, Kalangadan N, Prakash J, Sundaresan S, Govindarajan S, Rajaram K. Relative fitness of wild-type and phage-resistant pyomelanogenic P. aeruginosa and effects of combinatorial therapy on resistant formation. Heliyon. 2024. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40076.","journal-title":"Heliyon."},{"key":"789_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105732","author":"NN Laure","year":"2022","unstructured":"Laure NN, Ahn J. Phage resistance-mediated trade-offs with antibiotic resistance in Salmonella Typhimurium. Microb Pathog. 2022. https:\/\/doi.org\/10.1016\/j.micpath.2022.105732.","journal-title":"Microb Pathog"},{"key":"789_CR98","doi-asserted-by":"publisher","DOI":"10.1093\/ismeco\/ycae039","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Shu M, Zhang L, Zhong C, Liao N, Wu G. Phage-driven coevolution reveals trade-off between antibiotic and phage resistance in Salmonella anatum. ISME Commun. 2024. https:\/\/doi.org\/10.1093\/ismeco\/ycae039.","journal-title":"ISME Commun."},{"key":"789_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-00830-7","author":"F Gordillo Altamirano","year":"2021","unstructured":"Gordillo Altamirano F, Forsyth JH, Patwa R, Kostoulias X, Trim M, Subedi D, et al. Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials. Nat Microbiol. 2021. https:\/\/doi.org\/10.1038\/s41564-020-00830-7.","journal-title":"Nat Microbiol"},{"key":"789_CR100","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-micro-020518-115714","author":"E Geisinger","year":"2019","unstructured":"Geisinger E, Huo W, Hernandez-Bird J, Isberg RR. Acinetobacter baumannii: envelope determinants that control drug resistance, virulence, and surface variability. Annu Rev Microbiol. 2019. https:\/\/doi.org\/10.1146\/annurev-micro-020518-115714.","journal-title":"Annu Rev Microbiol"},{"key":"789_CR101","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00954-17","author":"RT Schooley","year":"2017","unstructured":"Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother. 2017. https:\/\/doi.org\/10.1128\/AAC.00954-17. (Erratum in: Antimicrob Agents Chemother. 2018; 10.1128\/AAC.02221-18).","journal-title":"Antimicrob Agents Chemother"},{"key":"789_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31455-5","author":"M Liu","year":"2022","unstructured":"Liu M, Hernandez-Morales A, Clark J, Le T, Biswas B, Bishop-Lilly KA, et al. Comparative genomics of Acinetobacter baumannii and therapeutic bacteriophages from a patient undergoing phage therapy. Nat Commun. 2022. https:\/\/doi.org\/10.1038\/s41467-022-31455-5.","journal-title":"Nat Commun"},{"key":"789_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0048-6","author":"D Du","year":"2018","unstructured":"Du D, Wang-Kann X, Neuberger A, van Veen HW, Pos KM, Piddock LJV, et al. Multidrug efflux pumps: structure, function and regulation. Nat Rev Microbiol. 2018. https:\/\/doi.org\/10.1038\/s41579-018-0048-6.","journal-title":"Nat Rev Microbiol"},{"key":"789_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/srep26717","author":"BK Chan","year":"2016","unstructured":"Chan BK, Sistrom M, Wertz JE, Kortright KE, Narayan D, Turner PE. Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Sci Rep. 2016. https:\/\/doi.org\/10.1038\/srep26717.","journal-title":"Sci Rep"},{"key":"789_CR105","doi-asserted-by":"publisher","DOI":"10.1093\/emph\/eoaa026","author":"J Gurney","year":"2020","unstructured":"Gurney J, Pradier L, Griffin JS, Gougat-Barbera C, Chan BK, Turner PE, et al. Phage steering of antibiotic-resistance evolution in the bacterial pathogen, Pseudomonas aeruginosa. Evol Med Public Health. 2020. https:\/\/doi.org\/10.1093\/emph\/eoaa026.","journal-title":"Evol Med Public Health."},{"key":"789_CR106","doi-asserted-by":"publisher","DOI":"10.1093\/emph\/eoy005","author":"BK Chan","year":"2018","unstructured":"Chan BK, Turner PE, Kim S, Mojibian HR, Elefteriades JA, Narayan D. Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. Evol Med Public Health. 2018. https:\/\/doi.org\/10.1093\/emph\/eoy005.","journal-title":"Evol Med Public Health."},{"key":"789_CR107","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1919888117","author":"AR Burmeister","year":"2020","unstructured":"Burmeister AR, Fortier A, Roush C, Lessing AJ, Bender RG. Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance. Proc Natl Acad Sci USA. 2020. https:\/\/doi.org\/10.1073\/pnas.1919888117.","journal-title":"Proc Natl Acad Sci USA"},{"key":"789_CR108","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01514-21","author":"KE Kortright","year":"2022","unstructured":"Kortright KE, Done RE, Chan BK, Souza V, Turner PE. Selection for phage resistance reduces virulence of Shigella flexneri. Appl Environ Microbiol. 2022. https:\/\/doi.org\/10.1128\/AEM.01514-21.","journal-title":"Appl Environ Microbiol"},{"key":"789_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137084","author":"NC Esteves","year":"2022","unstructured":"Esteves NC, Scharf BE. Flagellotropic bacteriophages: opportunities and challenges for antimicrobial applications. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23137084.","journal-title":"Int J Mol Sci"},{"key":"789_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2024.102471","author":"AG de Melo","year":"2024","unstructured":"de Melo AG, Morency C, Moineau S. Virulence-associated factors as targets for phage infection. Curr Opin Microbiol. 2024. https:\/\/doi.org\/10.1016\/j.mib.2024.102471.","journal-title":"Curr Opin Microbiol"},{"key":"789_CR111","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuaa041","author":"K Schroven","year":"2021","unstructured":"Schroven K, Aertsen A, Lavigne R. Bacteriophages as drivers of bacterial virulence and their potential for biotechnological exploitation. FEMS Microbiol Rev. 2021. https:\/\/doi.org\/10.1093\/femsre\/fuaa041.","journal-title":"FEMS Microbiol Rev"},{"key":"789_CR112","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.009980","author":"M Gutierrez-Rodarte","year":"2019","unstructured":"Gutierrez-Rodarte M, Kolappan S, Burrell BA, Craig L. The Vibrio cholerae minor pilin TcpB mediates uptake of the cholera toxin phage CTX\u03d5. J Biol Chem. 2019. https:\/\/doi.org\/10.1074\/jbc.RA119.009980.","journal-title":"J Biol Chem"},{"key":"789_CR113","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73679","author":"M Castledine","year":"2022","unstructured":"Castledine M, Padfield D, Sierocinski P, Soria Pascual J, Hughes A, M\u00e4kinen L, et al. Parallel evolution of Pseudomonas aeruginosa phage resistance and virulence loss in response to phage treatment in vivo and in vitro. Elife. 2022. https:\/\/doi.org\/10.7554\/eLife.73679.","journal-title":"Elife"},{"key":"789_CR114","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00926-19","author":"MR Mangalea","year":"2020","unstructured":"Mangalea MR, Duerkop BA. Fitness trade-offs resulting from bacteriophage resistance potentiate synergistic antibacterial strategies. Infect Immunity. 2020. https:\/\/doi.org\/10.1128\/iai.00926-19.","journal-title":"Infect Immunity."},{"key":"789_CR115","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2023.2290849","author":"J Wang","year":"2023","unstructured":"Wang J, Zheng C, Zhang Q, Sun L, Liu H, Cheng H. Phage selection drives resistance-virulence trade-offs in Ralstonia solanacearum plant-pathogenic bacterium irrespective of the growth temperature. Virulence. 2023. https:\/\/doi.org\/10.1080\/21505594.2023.2290849.","journal-title":"Virulence."},{"key":"789_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1280265","author":"JC Garc\u00eda-Cruz","year":"2024","unstructured":"Garc\u00eda-Cruz JC, Rebollar-Juarez X, Limones-Martinez A, Santos-Lopez CS, Toya S, Maeda T, et al. Resistance against two lytic phage variants attenuates virulence and antibiotic resistance in Pseudomonas aeruginosa. Front Cell Infect Microbiol. 2024. https:\/\/doi.org\/10.3389\/fcimb.2023.1280265.","journal-title":"Front Cell Infect Microbiol"},{"key":"789_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14010076","author":"\u00c1 R\u00f3zsa","year":"2025","unstructured":"R\u00f3zsa \u00c1, Orosz L, Szemer\u00e9di N, Spengler G, Kecskem\u00e9ti G, V\u00e1g\u00f3 O, et al. Bacteriophage treatment induces phenotype switching and alters antibiotic resistance of ESBL Escherichia coli. Antibiotics. 2025. https:\/\/doi.org\/10.3390\/antibiotics14010076.","journal-title":"Antibiotics"},{"key":"789_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0437-z","author":"RM Dedrick","year":"2019","unstructured":"Dedrick RM, Guerrero-Bustamante CA, Garlena RA, Russell DA, Ford K, Harris K, et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med. 2019. https:\/\/doi.org\/10.1038\/s41591-019-0437-z.","journal-title":"Nat Med"},{"key":"789_CR119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003957","author":"LJ Marinelli","year":"2008","unstructured":"Marinelli LJ, Piuri M, Swigo\u0148ov\u00e1 Z, Balachandran A, Oldfield LM, van Kessel JC, et al. BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes. PLoS ONE. 2008. https:\/\/doi.org\/10.1371\/journal.pone.0003957.","journal-title":"PLoS ONE"},{"key":"789_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031061","author":"CH Wang","year":"2020","unstructured":"Wang CH, Hsieh YH, Powers ZM, Kao CY. Defeating antibiotic-resistant bacteria: exploring alternative therapies for a post-antibiotic era. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21031061.","journal-title":"Int J Mol Sci"},{"key":"789_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/ph18030402","author":"ME Elshobary","year":"2025","unstructured":"Elshobary ME, Badawy NK, Ashraf Y, Zatioun AA, Masriya HH, Ammar MM, et al. Combating antibiotic resistance: Mechanisms, multidrug-resistant pathogens, and novel therapeutic approaches: an updated review. Pharmaceuticals. 2025. https:\/\/doi.org\/10.3390\/ph18030402.","journal-title":"Pharmaceuticals"},{"key":"789_CR122","doi-asserted-by":"publisher","DOI":"10.53771\/ijlsra.2025.9.1.0042","author":"IN Onyeyili","year":"2025","unstructured":"Onyeyili IN, Ogbozor FI, Kehinde AB, Ohaekwe C, Ovada E, Ali V, et al. Phage-based CRISPR delivery systems for targeted eradication of drug-resistant bacterial infections. Int J Life Sci Res. 2025. https:\/\/doi.org\/10.53771\/ijlsra.2025.9.1.0042.","journal-title":"Int J Life Sci Res."},{"key":"789_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04323-4","author":"A Saffari Natanzi","year":"2025","unstructured":"Saffari Natanzi A, Poudineh M, Karimi E, Khaledi A, Haddad KH. Innovative approaches to combat antibiotic resistance: integrating CRISPR\/Cas9 and nanoparticles against biofilm-driven infections. BMC Med. 2025. https:\/\/doi.org\/10.1186\/s12916-025-04323-4.","journal-title":"BMC Med"},{"key":"789_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01132-8","author":"Y Wu","year":"2021","unstructured":"Wu Y, Battalapalli D, Hakeem MJ, Selamneni V, Zhang P, Draz MS, et al. Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections. J Nanobiotechnology. 2021. https:\/\/doi.org\/10.1186\/s12951-021-01132-8.","journal-title":"J Nanobiotechnology."},{"key":"789_CR125","first-page":"236","volume-title":"Gene editing by CRISPR-Cas","author":"T Mehboob","year":"2026","unstructured":"Mehboob T, Tabassam N, Hameed H, Zaman M, Khan MA, Majeed I, et al. The CRISPR-Cas system in microbes. In: Ali A, Shafique F, editors., et al., Gene editing by CRISPR-Cas. Boca Raton: CRC Press; 2026. p. 236\u201357."},{"key":"789_CR126","doi-asserted-by":"publisher","DOI":"10.7150\/thno.42573","author":"H Liu","year":"2020","unstructured":"Liu H, Li H, Liang Y, Du X, Yang C, Yang L, et al. Phage-delivered sensitisation with subsequent antibiotic treatment reveals sustained effect against antimicrobial resistant bacteria. Theranostics. 2020. https:\/\/doi.org\/10.7150\/thno.42573.","journal-title":"Theranostics."},{"key":"789_CR127","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S370869","author":"S Tao","year":"2022","unstructured":"Tao S, Chen H, Li N, Liang W. The application of the CRISPR-Cas system in antibiotic resistance. Infect Drug Resist. 2022. https:\/\/doi.org\/10.2147\/IDR.S370869.","journal-title":"Infect Drug Resist."},{"key":"789_CR128","doi-asserted-by":"publisher","DOI":"10.4274\/mjima.galenos.2021.2021.46","author":"P Swaminathan","year":"2021","unstructured":"Swaminathan P, Sen S, Mandira MA, Prasad AA. Compounds and methods to resensitize antibiotic-resistant bacteria. Mediterr J Infect Microbe Antimicrob. 2021. https:\/\/doi.org\/10.4274\/mjima.galenos.2021.2021.46.","journal-title":"Mediterr J Infect Microbe Antimicrob."},{"key":"789_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/v13061013","author":"M Cie\u015blik","year":"2021","unstructured":"Cie\u015blik M, Bagi\u0144ska N, Jo\u0144czyk-Matysiak E, W\u0119grzyn A, W\u0119grzyn G, G\u00f3rski A. Temperate bacteriophages\u2014the powerful indirect modulators of eukaryotic cells and immune functions. Viruses. 2021. https:\/\/doi.org\/10.3390\/v13061013.","journal-title":"Viruses"},{"key":"789_CR130","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00504-24","author":"AM Al-Anany","year":"2024","unstructured":"Al-Anany AM, Fatima R, Nair G, Mayol JT, Hynes AP. Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny. MBio. 2024. https:\/\/doi.org\/10.1128\/mbio.00504-24.","journal-title":"MBio"},{"key":"789_CR131","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02559-24","author":"R Fatima","year":"2025","unstructured":"Fatima R, Hynes AP. Temperate phage-antibiotic synergy is widespread-extending to Pseudomonas-but varies by phage, host strain, and antibiotic pairing. MBio. 2025. https:\/\/doi.org\/10.1128\/mbio.02559-24.","journal-title":"MBio"},{"key":"789_CR132","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.05741-11","author":"R Edgar","year":"2012","unstructured":"Edgar R, Friedman N, Molshanski-Mor S, Qimron U. Reversing bacterial resistance to antibiotics by phage-mediated delivery of dominant sensitive genes. Appl Environ Microbiol. 2012. https:\/\/doi.org\/10.1128\/AEM.05741-11.","journal-title":"Appl Environ Microbiol"},{"key":"789_CR133","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012361","author":"S Kraus","year":"2024","unstructured":"Kraus S, Fletcher ML, \u0141api\u0144ska U, Chawla K, Baker E, Attrill EL, et al. Phage-induced efflux down-regulation boosts antibiotic efficacy. PLoS Pathog. 2024. https:\/\/doi.org\/10.1371\/journal.ppat.1012361.","journal-title":"PLoS Pathog"},{"key":"789_CR134","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01822-25","author":"A Tarasenko","year":"2025","unstructured":"Tarasenko A, Papudeshi BN, Grigson SR, Mallawaarachchi V, Hutton ALK, Warner MS, et al. Reprogramming resistance: phage-antibiotic synergy targets efflux systems in ESKAPEE pathogens. MBio. 2025. https:\/\/doi.org\/10.1128\/mbio.01822-25.","journal-title":"MBio"},{"key":"789_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2025.139151","author":"Y Wu","year":"2025","unstructured":"Wu Y, Tan D, Wang D, Ogendi GM, Balcazar JL, Zhu D, et al. Bacteriophage facilitated transmission of multidrug efflux pump regulatory genes in Pseudomonas aeruginosa. J Hazard Mater. 2025. https:\/\/doi.org\/10.1016\/j.jhazmat.2025.139151.","journal-title":"J Hazard Mater"},{"key":"789_CR136","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01393-24","author":"K Qin","year":"2024","unstructured":"Qin K, Shi X, Yang K, Xu Q, Wang F, Chen S, et al. Phage-antibiotic synergy suppresses resistance emergence of Klebsiella pneumoniae by altering the evolutionary fitness. MBio. 2024. https:\/\/doi.org\/10.1128\/mbio.01393-24.","journal-title":"MBio"},{"key":"789_CR137","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013546","author":"J Bulssico","year":"2025","unstructured":"Bulssico J, Panigrahi S, Matveeva M, Ginet N, Ansaldi M. Antibiotic-induced morphological changes enhance phage predation. PLoS Pathog. 2025. https:\/\/doi.org\/10.1371\/journal.ppat.1013546.","journal-title":"PLoS Pathog"},{"key":"789_CR138","first-page":"107","volume-title":"Bacterial biofilms. Current topics in microbiology and immunology","author":"K Lewis","year":"2008","unstructured":"Lewis K. Multidrug tolerance of biofilms and persister cells. In: Romeo T, editor. Bacterial biofilms. Current topics in microbiology and immunology. Berlin, Heidelberg: Springer; 2008. p. 107\u201331."},{"key":"789_CR139","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.1780","author":"J Marcinkiewicz","year":"2013","unstructured":"Marcinkiewicz J, Strus M, Pasich E. Antibiotic resistance: a \u201cdark side\u201d of biofilm-associated chronic infections. Pol Arch Med Wewn. 2013. https:\/\/doi.org\/10.20452\/pamw.1780.","journal-title":"Pol Arch Med Wewn"},{"key":"789_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178699","author":"K Paw\u0142uszkiewicz","year":"2025","unstructured":"Paw\u0142uszkiewicz K, Bus\u0142owicz T, Korgiel M, Faltus A, Kucharczyk E, Por\u0119bska B, et al. Bacteriophage-based approach against biofilm infections associated with medical devices: a narrative review of ESKAPE pathogens. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26178699.","journal-title":"Int J Mol Sci"},{"key":"789_CR141","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-025-00844-0","author":"M Cie\u015blik","year":"2025","unstructured":"Cie\u015blik M, W\u00f3jcicki M, Migda\u0142 P, Grygiel I, Bajrak O, Orwat F, et al. Fighting biofilm: bacteriophages eliminate biofilm formed by multidrug-resistant Enterobacter hormaechei on urological catheters. Med Microbiol Immunol. 2025. https:\/\/doi.org\/10.1007\/s00430-025-00844-0.","journal-title":"Med Microbiol Immunol"},{"key":"789_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1462620","author":"MM Islam","year":"2024","unstructured":"Islam MM, Mahbub NU, Shin WS, Oh MH. Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii. Front Cell Infect Microbiol. 2024. https:\/\/doi.org\/10.3389\/fcimb.2024.1462620.","journal-title":"Front Cell Infect Microbiol"},{"key":"789_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics7020029","author":"C S\u00e3o-Jos\u00e9","year":"2018","unstructured":"S\u00e3o-Jos\u00e9 C. Engineering of phage-derived lytic enzymes: improving their potential as antimicrobials. Antibiotics. 2018. https:\/\/doi.org\/10.3390\/antibiotics7020029.","journal-title":"Antibiotics"},{"key":"789_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1428637","author":"A Mayorga-Ramos","year":"2024","unstructured":"Mayorga-Ramos A, Carrera-Pacheco SE, Barba-Ostria C, Guam\u00e1n LP. Bacteriophage-mediated approaches for biofilm control. Front Cell Infect Microbiol. 2024. https:\/\/doi.org\/10.3389\/fcimb.2024.1428637.","journal-title":"Front Cell Infect Microbiol"},{"key":"789_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2023.100147","author":"E Akturk","year":"2023","unstructured":"Akturk E, Melo LDR, Oliveira H, Crabb\u00e9 A, Coenye T, Azeredo J. Combining phages and antibiotic to enhance antibiofilm efficacy against an in vitro dual species wound biofilm. Biofilm. 2023. https:\/\/doi.org\/10.1016\/j.bioflm.2023.100147.","journal-title":"Biofilm"},{"key":"789_CR146","doi-asserted-by":"publisher","DOI":"10.1159\/000487137","author":"M Yazdi","year":"2018","unstructured":"Yazdi M, Bouzari M, Ghaemi EA. Isolation and characterization of a lytic bacteriophage (vB_PmiS-TH) and Its application in combination with ampicillin against planktonic and biofilm forms of Proteus mirabilis isolated from urinary tract infection. J Mol Microbiol Biotechnol. 2018. https:\/\/doi.org\/10.1159\/000487137.","journal-title":"J Mol Microbiol Biotechnol"},{"key":"789_CR147","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10081-0","author":"S Rastegar","year":"2024","unstructured":"Rastegar S, Skurnik M, Tadjrobehkar O, Samareh A, Samare-Najaf M, Lotfian Z, et al. Synergistic effects of bacteriophage cocktail and antibiotics combinations against extensively drug-resistant Acinetobacter baumannii. BMC Infect Dis. 2024. https:\/\/doi.org\/10.1186\/s12879-024-10081-0.","journal-title":"BMC Infect Dis"},{"key":"789_CR148","doi-asserted-by":"publisher","DOI":"10.3390\/v17060778","author":"M W\u00f3jcicki","year":"2025","unstructured":"W\u00f3jcicki M, Soko\u0142owska B, G\u00f3rski A, Jo\u0144czyk-Matysiak E. Dual nature of bacteriophages: friends or foes in minimally processed food products\u2014a comprehensive review. Viruses. 2025. https:\/\/doi.org\/10.3390\/v17060778.","journal-title":"Viruses"},{"key":"789_CR149","doi-asserted-by":"publisher","DOI":"10.1089\/phage.2022.0001","author":"CF Am\u00e1bile-Cuevas","year":"2022","unstructured":"Am\u00e1bile-Cuevas CF. Phage therapies: lessons (not) learned from the \u201cantibiotic era.\u201d PHAGE-Ther Appl Res. 2022. https:\/\/doi.org\/10.1089\/phage.2022.0001.","journal-title":"PHAGE-Ther Appl Res."}],"container-title":["BioDrugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-026-00789-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40259-026-00789-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-026-00789-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:38:15Z","timestamp":1783330695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40259-026-00789-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":149,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["789"],"URL":"https:\/\/doi.org\/10.1007\/s40259-026-00789-7","relation":{"references":[{"id-type":"doi","id":"10.3390\/foods13162519","asserted-by":"subject"}]},"ISSN":["1173-8804","1179-190X"],"issn-type":[{"value":"1173-8804","type":"print"},{"value":"1179-190X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"27 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Conceptualization: Micha\u0142 W\u00f3jcicki, Martyna Cie\u015blik, Andrzej G\u00f3rski, Ewa Jo\u0144czyk-Matysiak; Data curation: Micha\u0142 W\u00f3jcicki, Martyna Cie\u015blik, Ewa Jo\u0144czyk-Matysiak; Writing\u2014original draft: Micha\u0142 W\u00f3jcicki, Martyna Cie\u015blik, Ewa Jo\u0144czyk-Matysiak; Writing\u2014review & editing: Micha\u0142 W\u00f3jcicki, Martyna Cie\u015blik, Andrzej G\u00f3rski, Ewa Jo\u0144czyk-Matysiak. All authors read and approved the final version of the manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"ChatGPT (OpenAI, version GPT-5) was used solely to support linguistic refinement. Specific sections (typically one paragraph at a time) were input to improve grammatical correctness and clarity of expression. All scientific content, interpretation, structure, and argumentation remained entirely author-driven and were manually reviewed following AI-assisted suggestions. No part of the text was generated or used verbatim from the model without manual oversight and verification.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of AI-Based Tools and Technologies"}}]}}